China's largest biotechnology company and a non-profit product developer are teaming up to develop new tuberculosis vaccines.

Indian health officials are describing hard to treat cases of TB as 'extra XDR-TB' amid warnings that the disease is not being managed properly.

Silk 'chips' capable of diagnosing a range of diseases in a matter of minutes could be ready for market by early 2013.

Global funding for R&D on neglected diseases has suffered a blow, with funders pulling out in the wake of the economic crisis.

A panel set up to review the finances of the Global Fund after the misuse of its grants has recommended a substantial overhaul.

Growing bacteria emit heat that might provide the quick, cheap TB diagnosis the developing world needs, say scientists.

A urine test for TB may be a boon for developing countries for cheapness and accuracy.

Commercial blood tests for tuberculosis are unreliable and should not be used, says the WHO, calling for more research.

A new centre will train African researchers to develop drugs for diseases neglected by large pharmaceutical companies.

The first-of-its-kind searchable website is expected to help researchers and policymakers deal with the disease.

India plans to make a portion of its indigenous knowledge library open access, to enable the development of drugs for diseases of the poor.

A tuberculosis test that detects antibodies in the blood will provide quick, cheap results, Bangladeshi scientists say.

India must invest in public health, say experts.

Many commercially available TB tests could be worsening the epidemic, says the WHO expert group on TB diagnostics.

A study has found that rats can detect TB better than laboratory tests, challenging the medical community's scepticism over the method.

A TB test that can detect more than 90 per cent of cases has been endorsed by the WHO, which has hailed it as a breakthrough.

Developing countries have tuberculosis vaccines ready for trials but a lack of funding may keep them in the lab, a conference heard.

Trials of promising TB vaccines face huge obstacles that will delay progress by at least five years, a conference has heard.

Tuberculosis experts are gathering in Estonia this week to put together a blueprint for the development of TB vaccines.

Field trials suggest that a new tuberculosis test could dramatically improve detection rates, but there are still hurdles such as cost.